DexCom

$321.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 9:36 AM EST today

Why Robinhood?

You can buy or sell DexCom and other stocks, options, and ETFs commission-free!

About DXCM

DexCom, Inc. Common Stock, also called DexCom, is a medical device manufacturing company. The firm engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA. The listed name for DXCM is DexCom, Inc. Common Stock.

CEO
Kevin Ronald Sayer
Employees
5,200
Headquarters
San Diego, California
Founded
1999
Market Cap
30.81B
Price-Earnings Ratio
130.88
Dividend Yield
Average Volume
1.14M
High Today
$323.00
Low Today
$319.48
Open Price
$323.00
Volume
25.37K
52 Week High
$456.23
52 Week Low
$182.07

Collections

DXCM Earnings

-$0.16
$0.28
$0.71
$1.15
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 11, After Hours

You May Also Like